Developmental effects of dietary n-3 fatty acids on activity and response to novelty.
Insufficient availability of n-3 polyunsaturated fatty acids (PUFA) during pre- and neonatal development decreases accretion of docosahexaenoic acid (DHA, 22:6n-3) in the developing brain. Low tissue levels of DHA are associated with neurodevelopmental disorders including attention deficit hyperactivity disorder (ADHD). In this study, 1st- and 2nd-litter male Long-Evans rats were raised from conception on a Control diet containing alpha-linolenic acid (4.20 g/kg diet), the dietarily essential fatty acid precursor of DHA, or a diet Deficient in alpha-linolenic acid (0.38 g/kg diet). The Deficient diet resulted in a decrease in brain phospholipid DHA of 48% in 1st-litter pups and 65% in 2nd-litter pups. Activity, habituation, and response to spatial change in a familiar environment were assessed in a single-session behavioral paradigm at postnatal days 28 and 70, inclusive. Activity and habituation varied by age with younger rats exhibiting higher activity, less habituation, and less stimulation of activity induced by spatial novelty. During the first and second exposures to the test chamber, 2nd-litter Deficient pups exhibited higher levels of activity than Control rats or 1st-litter Deficient pups, and less habituation during the first exposure, but were not more active after introduction of a novel spatial stimulus. The higher level of activity in a familiar environment, but not after introduction of a novel stimulus is consistent with clinical observations in ADHD. The observation of this effect only in 2nd-litter rats fed the Deficient diet suggests that brain DHA content, rather than dietary n-3 PUFA content, likely underlies these effects.
Levant
Beth
B
Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA. blevant@kumc.edu
Zarcone
Troy J
TJ
Fowler
Stephen C
SC
D000704:Analysis of Variance; D000818:Animals; D001245:Association Learning / Q000502:physiology; D001289:Attention Deficit Disorder with Hyperactivity / Q000378:metabolism*; D001921:Brain / Q000254:growth & development / Q000378:metabolism*; D004041:Dietary Fats / Q000378:metabolism; D004195:Disease Models, Animal; D004281:Docosahexaenoic Acids / Q000378:metabolism*; D005106:Exploratory Behavior / Q000502:physiology*; D006185:Habituation, Psychophysiologic / Q000502:physiology; D008297:Male; D009043:Motor Activity / Q000502:physiology*; D051381:Rats; D020318:Rats, Long-Evans; D017962:alpha-Linolenic Acid / Q000172:deficiency / Q000378:metabolism*
D004041:Dietary Fats; D017962:alpha-Linolenic Acid; D004281:Docosahexaenoic Acids
Nutr Neurosci. 2010 Aug;13(4):161-9
20670471
Clin Pediatr (Phila). 1987 Aug;26(8):406-11
2439249
Dev Psychobiol. 1983 Mar;16(2):83-109
6339302
Pediatrics. 1981 Jan;67(1):13-7
7243422
Am J Clin Nutr. 2002 Apr;75(4):662-7
11916751
Pharmacol Biochem Behav. 1999 Dec;64(4):821-6
10593206
Psychopharmacology (Berl). 1991;105(1):93-100
1745717
Lipids. 1991 Mar;26(3):203-8
2046487
J Neurosci Methods. 2001 May 30;107(1-2):107-24
11389948
Behav Brain Res. 1998 Jul;94(1):11-24
9708835
J Lipid Res. 2007 Nov;48(11):2471-7
17703057
Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):329-49
16949263
Physiol Behav. 1994 Feb;55(2):231-9
8153160
Ann N Y Acad Sci. 1969 Jul 30;159(3):1059-70
5260289
J Nutr. 1993 Nov;123(11):1939-51
8229312
Neurosci Lett. 1998 Jan 16;240(3):177-81
9502233
Psychoneuroendocrinology. 2008 Oct;33(9):1279-92
18707812
J Pharmacol Exp Ther. 1995 Oct;275(1):345-57
7562570
Neuropharmacology. 2009 Dec;57(7-8):636-9
19715711
J Nutr. 2007 Jan;137(1):125-9
17182812
Dev Neurosci. 2000 Sep-Dec;22(5-6):474-80
11111165
Eur J Pediatr. 2010 Feb;169(2):149-64
19672626
Neurosci Lett. 2000 Apr 21;284(1-2):25-8
10771153
Psychopharmacologia. 1972;24(1):99-106
4622973
Dev Med Child Neurol. 2009 Aug;51(8):580-92
19549202
Physiol Behav. 2006 Sep 30;89(2):196-204
16875705
J Neurochem. 1996 Apr;66(4):1582-91
8627314
Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):299-308
16962757
J Abnorm Child Psychol. 1989 Aug;17(4):371-91
2794253
Nutr J. 2008 Feb 14;7:8
18275609
J Lipid Res. 2000 Jan;41(1):32-40
10627499
J Neurosci Methods. 2010 May 30;189(1):36-43
20346982
Lipids. 2001 Sep;36(9):859-71
11724458
Am J Clin Nutr. 1995 Oct;62(4):761-8
7572706
Lipids. 2006 May;41(5):407-14
16933785
Biol Psychiatry. 2006 Nov 15;60(10):1053-61
16893529
Nutr Neurosci. 2003 Oct;6(5):277-81
14609313
J Neurochem. 2008 Jul;106(2):662-71
18410511
Behav Brain Res. 1998 Jul;94(1):1-10
9708834
Behav Brain Res. 2007 Jun 18;180(2):119-26
17397943
Neurosci Biobehav Rev. 2006;30(7):1045-64
16774787
J Am Acad Child Adolesc Psychiatry. 1996 Feb;35(2):204-14
8720630
Am J Clin Nutr. 2000 Jan;71(1 Suppl):327S-30S
10617991
J Nutr. 2006 Aug;136(8):2236-42
16857847
Behav Brain Res. 2004 Jun 4;152(1):49-57
15135968
J Nutr. 2007 Nov;137(11):2425-30
17951480
Arch Gen Psychiatry. 1983 Jun;40(6):688-93
6847336
J Pharmacol Exp Ther. 1995 Dec;275(3):1090-8
8531068
Neurosci Lett. 2008 Jun 27;438(3):303-7
18499349
Lipids. 1999;34 Suppl:S251
10419169